Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@jax.org
Gene | TP53 |
Variant | R273H |
Impact List | missense |
Protein Effect | loss of function |
Gene Variant Descriptions | TP53 R273H is a hotspot mutation that lies within the DNA binding domain of the Tp53 protein (PMID: 22713868). R273H disrupts Dnmt3a complex formation similar to wild-type Tp53 (PMID: 31640986), however, results in a loss of DNA binding and decreased activation of Tp53 target gene expression, leads to resistance to apoptosis and failure of G1 arrest in cell culture (PMID: 31395785), and also confers a gain of function to Tp53, resulting in aberrant transcriptional activation and increased cell migration (PMID: 22114072, PMID: 14743206, PMID: 32002804). |
Associated Drug Resistance | |
Category Variants Paths |
TP53 mutant TP53 exon8 TP53 R273X TP53 R273H TP53 mutant TP53 inact mut TP53 R273H |
Transcript | NM_000546.6 |
gDNA | chr17:g.7673802C>T |
cDNA | c.818G>A |
Protein | p.R273H |
Source Database | RefSeq |
Genome Build | GRCh38/hg38 |
Transcript | gDNA | cDNA | Protein | Source Database | Genome Build |
---|---|---|---|---|---|
NM_001126114.2 | chr17:g.7673802C>T | c.818G>A | p.R273H | RefSeq | GRCh38/hg38 |
NM_001407262.1 | chr17:g.7673802C>T | c.818G>A | p.R273H | RefSeq | GRCh38/hg38 |
NM_001407266.1 | chr17:g.7673802C>T | c.818G>A | p.R273H | RefSeq | GRCh38/hg38 |
NM_000546.6 | chr17:g.7673802C>T | c.818G>A | p.R273H | RefSeq | GRCh38/hg38 |
NM_001126113.3 | chr17:g.7673802C>T | c.818G>A | p.R273H | RefSeq | GRCh38/hg38 |
NM_001126114 | chr17:g.7673802C>T | c.818G>A | p.R273H | RefSeq | GRCh38/hg38 |
NM_001126113.2 | chr17:g.7673802C>T | c.818G>A | p.R273H | RefSeq | GRCh38/hg38 |
NM_001126114.3 | chr17:g.7673802C>T | c.818G>A | p.R273H | RefSeq | GRCh38/hg38 |
NM_001407268.1 | chr17:g.7673802C>T | c.818G>A | p.R273H | RefSeq | GRCh38/hg38 |
NM_001407270.1 | chr17:g.7673802C>T | c.818G>A | p.R273H | RefSeq | GRCh38/hg38 |
NM_001126112 | chr17:g.7673802C>T | c.818G>A | p.R273H | RefSeq | GRCh38/hg38 |
NM_000546 | chr17:g.7673802C>T | c.818G>A | p.R273H | RefSeq | GRCh38/hg38 |
NM_000546.5 | chr17:g.7673802C>T | c.818G>A | p.R273H | RefSeq | GRCh38/hg38 |
NM_001126112.3 | chr17:g.7673802C>T | c.818G>A | p.R273H | RefSeq | GRCh38/hg38 |
NM_001126113 | chr17:g.7673802C>T | c.818G>A | p.R273H | RefSeq | GRCh38/hg38 |
NM_001126112.2 | chr17:g.7673802C>T | c.818G>A | p.R273H | RefSeq | GRCh38/hg38 |
NM_001407264.1 | chr17:g.7673802C>T | c.818G>A | p.R273H | RefSeq | GRCh38/hg38 |
Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
---|---|---|---|---|---|---|---|
TP53 R273H TP53 P309S | colorectal cancer | sensitive | NSC59984 | Preclinical - Cell culture | Actionable | In a preclinical study, treatment with NSC59984 induced Tp53 pathway signaling, degradation of mutant Tp53, and cell death in a colorectal cancer cell line harboring TP53 R273H and TP53 P309S in culture (PMID: 26294215). | 26294215 |
TP53 R273H TP53 P309S | colorectal cancer | sensitive | Cisplatin + NSC59984 | Preclinical - Cell culture | Actionable | In a preclinical study, the combination of Platinol (cisplatin) and NSC59984 worked synergistically to decrease viability of a colorectal cancer cell line harboring TP53 R273H and TP53 P309S in culture (PMID: 26294215). | 26294215 |
BRAF V600E PIK3CA P449T TP53 R273H | colorectal cancer | sensitive | PD-0325901 + Sapanisertib | Preclinical - Cell line xenograft | Actionable | In a preclinical study, Sapanisertib (MLN0128) and PD-0325901 synergistically inhibited Erk and PI3K signaling and growth of colorectal cancer cells harboring BRAF V600E, PIK3CA P449T, and TP53 R273H in culture and in cell line xenograft models, but did not have synergistic effect on apoptosis (PMID: 26272063). | 26272063 |